Vaccination with Mycobacterium bovis BCG affects the distribution of Fc receptor-bearing T lymphocytes in experimental pulmonary tuberculosis. by R A Bartow & D N McMurray
Vol. 57, No. 5INFECTION AND IMMUNITY, May 1989, p. 1374-1379
0019-9567/89/051374-06$02.00/0
Copyright © 1989, American Society for Microbiology
Vaccination with Mycobacterium bovis BCG Affects the Distribution
of Fc Receptor-Bearing T Lymphocytes in Experimental
Pulmonary Tuberculosis
REBECCA A. BARTOW* AND DAVID N. McMURRAY
Department of Medical Microbiology and Immunology, College of Medicine, Texas A&M University,
College Station, Texas 77843
Received 17 October 1988/Accepted 20 January 1989
Inbred strain 2 guinea pigs were vaccinated with Mycobacterium bovis BCG or were left unvaccinated and
challenged 6 weeks later by the respiratory route with virulent Mycobacterium tuberculosis. By using a double
rosette assay with isotype-specific antibody-coated ox and uncoated rabbit erythrocytes, the proportions of T
lymphocytes bearing Fc receptors for immunoglobulin G (IgG) (Ty cells) or IgM (T,u cells) were quantified in
tissues taken from animals that were killed within 4 weeks postchallenge. Tuberculin reactivity in vivo and in
vitro and antimycobacterial resistance were also measured. BCG vaccination protected the guinea pigs and
resulted in significantly enhanced proportions of T,u cells in the blood during the first 2 weeks and in the spleen
during weeks 2 and 3 postchallenge. Levels of T-y cells declined in all tissues during the first 3 weeks of infection
and were unaffected by prior vaccination with BCG. Increased proportions of T,u cells in the blood were
accompanied by dramatic tuberculin skin reactions and purified protein derivative-induced lymphoprolifera-
tion in BCG-vaccinated guinea pigs during the first 2 weeks following virulent pulmonary challenge. Peak levels
of T,u cells in the spleens of vaccinated animals at 2 weeks coincided with the first appearance of virulent
mycobacteria in that organ. BCG vaccination appears to influence immunoregulatory events in pulmonary
tuberculosis through effects on the distribution of IgM Fe receptor-bearing (T,u cell) T lymphocytes.
Although more than a century has elapsed since Robert
Koch discovered the tubercle bacillus (9), detailed knowl-
edge of relevant immune responses, particularly mecha-
nisms regulating acquired anti-tuberculosis resistance, are
incompletely understood. Tuberculosis remains a major
cause of morbidity and mortality in developing countries,
while also resurging in certain areas of the United States
because of its role as an opportunistic pathogen in patients
with acquired immune deficiency syndrome. Global control
of tuberculosis relies primarily on the only vaccine that is
currently available, Mycobacterium bovis BCG. Unfortu-
nately, BCG vaccination has failed to consistently induce
protective immunity in human field trials (1, 25). This finding
suggests the need to define the cellular interactions that
operate to regulate protection in patients with tuberculosis.
The spectrum of immune responses against tuberculous
infection ranges from protective immunity to immunosup-
pression, with the thymus-dependent (T) cell being a central
participant in both (1). T-cell heterogeneity has been defined
in most studies of tuberculous immunity by the presence of
phenotypic surface markers for helper and inducer (CD4) or
suppressor and cytotoxic (CD8) T cells, which are not
always consonant with a particular T-cell function (5, 6).
Therefore, functional surface receptors (e.g., Fc receptors
and E rosette) may prove to be more relevant for delineating
the T-cell subsets that are involved in successful anti-
mycobacterial immunity.
In early work dissecting regulatory T-cell circuits, Moretta
et al. (16) associated helper activity with the subpopulation
of T lymphocytes that bear Fc receptors (FcR+) for immu-
noglobulin M (IgM) (T,u cells), while ascribing a suppressor
function to T cells that bind IgG (Ty cells). FcR+ lympho-
cytes have been implicated in the regulation of B cells that
* Corresponding author.
produce antibodies of the homologous isotype (11, 14) and in
antibody-mediated cytotoxic reactions (17, 18). While it is
now apparent that the T,u and T-y cells may not comprise
functionally distinct and unique subpopulations, there is
evidence for the importance of FcR+ T lymphocytes in
resistance to tuberculosis. In a recent clinical study, Klein-
henz and Ellner (8) have reported increased levels ofTy cells
in the peripheral blood. of patients with active pulmonary
tuberculosis in the absence of detectable alterations in the
suppressor cell population characterized by the phenotypic
marker Leu2a. They concluded that the T-y-cell population
may mediate antigen-specific suppression, as evidenced by
an enhanced proliferative response of cultured cells also to
purified protein derivative (PPD) following depletion of the
Ty-cell subset. In the same study, Ty cells also were capable
of modulating antigen-specific suppression by monocytes,
possibly functioning as contrasuppressor cells (8).
In this study, using a well-established guinea pig model of
experimental pulmonary tuberculosis (2, 21), we examined
the effects of BCG vaccination on in vivo and in vitro
parameters of cellular immunity. Using a double rosette
assay, we assessed vaccine-related changes in T-y- and
T,u-cell distribution in guinea pigs infected aerogenically
with virulent Mycobacterium tuberculosis.
(This study was previously presented in part [R. A.
Bartow, C. L. Mintzer, and D. N. McMurray, Abstr. Annu.
Meet. Am. Soc. Microbiol. 1988, U48, p. 140].)
MATERIALS AND METHODiS
Experimental animals. Pathogen-free strain 2 inbred
guinea pigs (males and females; weight, 150 to 250 g) were
obtained from a commercial supplier (Veterinary Resources
Division, University of Texas System Science Park, Bas-
trop, Tex.). The animals were housed individually in poly-
carbonate cages with stainless steel grid floors and feeders
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and were given commercial guinea pig chow and tap water
ad libitum. Each animal was randomly assigned to a vacci-
nation treatment.
BCG vaccination. Guinea pigs in vaccination groups re-
ceived a subcutaneous injection of 0.2 ml of M. bovis BCG
(Copenhagen 1331; Statens Seruminstitut, Copenhagen,
Denmark) in the left inguinal region. The lyophilized BCG
vaccine was reconstituted with sterile physiological saline to
deliver approximately 103 viable organisms per animal.
Respiratory infection. M. tuberculosis H37Rv (ATCC
27294) was obtained from the American Type Culture Col-
lection (Rockville, Md.) and was stored as a single-cell
suspension at -70°C (4).
Six weeks following BCG vaccination, all guinea pigs were
infected via the respiratory route by using an aerosol cham-
ber as described previously (27). The infecting inoculum of
virulent M. tuberculosis H37Rv introduced into the nebu-
lizer was adjusted empirically to result in the inhalation and
retention of approximately 20 viable organisms per animal.
The infection was performed in a biohazard facility designed
for use with class 3 human microbial pathogens. Exposure of
groups of guinea pigs that were selected randomly from the
vaccination treatments resulted in uniform, reproducible
infection of all animals with mycobacteria.
PPD skin tests. All animals were shaved on the right side
and injected intradermally with 0.1 ml of PPD (PPD-RT23;
Statens Seruminstitut) containing 100 tuberculin units.
These injections were done 24 h before the animals were
sacrificed, and the mean diameter of the induration was
measured at the time of sacrifice. In preliminary experi-
ments, we determined that PPD skin testing per se does not
influence significantly the lymphoproliferative response.
Necropsy procedure. Directly prior to necropsy, diameters
of indurations resulting from the skin test were measured.
Guinea pigs were killed by the intramuscular injection of 1 to
3 ml of sodium pentobarbital (Fort Dodge Laboratories,
Inc., Fort Dodge, Iowa) at 1, 2, 3, and 4 weeks following
respiratory infection. A blood sample of 5 to 10 ml was
obtained immediately via cardiac puncture with a 10-ml
heparinized syringe. Recovery of viable M. tuberciilosis was
accomplished by aseptically removing the spleen, weighing
it, and homogenizing half of it in sterile saline with a Teflon
(E. I. du Pont de Nemours & Co., Inc., Wilmington,
Del.)-glass homogenizer. Homogenates were diluted 10-fold
in sterile saline and streaked in duplicate onto M7H10 agar
plates. After 2 to 3 weeks of incubation at 37°C, the number
of colonies was counted and expressed as the mean log1o
viable M. tuberculosis H37Rv organisms per gram of spleen
tissue. A single-cell suspension was prepared by gently
homogenizing the remainder of the spleen in a sterile Ten
Broeck homogenizer in tissue culture medium (RPMI 1640).
Lymphocyte blastogenesis. Mitogen- and antigen-induced
lymphoproliferation was assessed in vitro by an established
procedure (2). Total leukocyte count determination was
performed on each blood sample by standard clinical proce-
dures. Lymphocytes from peripheral blood were separated
by density gradient centrifugation on lymphocyte separation
medium (Organon Teknika Corp., Durham, N.C.). Lympho-
cytes at the interface were removed and washed three times
in phosphate-buffered saline with 2% fetal bovine serum.
The viability of blood lymphocytes was determined by
trypan blue exclusion and counting in a hemacytometer.
After the viability was determined, the cells were suspended
in RPMI 1640 medium containing 10% fetal bovine serum,
penicillin (100 U/ml), streptomycin (100 ,ug/ml), 2-mercapto-
ethanol (10 ,uM), and L-glutamine (2 jLM) and placed into
wells (2 x 105 cells per well) of microtiter plates (Corning
Glass Works, Corning, N.Y.). Triplicate cultures were stim-
ulated with PPD (Statens Seruminstitut) at final concentra-
tions of 50, 25, and 12.5 pug/ml and concanavalin A (ConA;
Sigma Chemical Co., St. Louis, Mo.) at final concentrations
of 40. 20, and 10 Fg/ml. Control cultures received cells and
medium alone. The cells were then incubated for 4 days at
37°C in a 5% CO2 atmosphere. On the final day of incuba-
tion, the cells were labeled for 6 h with 0.8 ,uCi of tritiated
thymidine (6.7 Ci/mmol; Dupont, NEN Research Products,
Boston, Mass.). The cultures were then harvested onto fiber
glass filter disks and counted in a liquid scintillation counter
(LS8000; Beckman Instruments, Inc., Fullerton, Calif.). The
data for the concentration of mitogen or antigen eliciting
maximum proliferation are expressed as a stimulation index,
defined as a ratio of mean counts per minute in stimulated
cultures to that of unstimulated cultures of the same cells.
Double rosette assay. Using a published protocol (19), we
quantified T cells bearing Fc receptors for either IgG (T-y
cell) or IgM (T,u cell) in the same cell suspensions used for
the blastogenesis assay. Commercial affinity-purified rabbit
IgM or IgG antibodies (Cappel Laboratories, Cochranville,
Pa.) directed against ox erythrocytes were used to coat ox
erythrocytes with either antibody isotype to create cells that
bound to T-y lymphocytes (EA-y) or T,u lymphocytes (EA,u).
Ox erythrocytes were incubated for 30 min at 37°C with an
equal volume of anti-ox erythrocyte IgG or anti-ox erythro-
cyte IgM diluted to the appropriate concentration in sterile
saline. EA,u and EA-y suspensions were washed three times
with phosphate-buffered saline, suspended in supplemented
RPMI 1640 medium, and stored at 4°C until use. The blood
and spleen cell suspensions were placed in sterile, plastic
petri dishes and incubated for 1 h at 37°C to remove adherent
cells. Nonadherent cells were collected and washed three
times in RPMI 1640 medium. The viable lymphocyte con-
centration was adjusted to 106 cells per ml. Guinea pig
lymphocytes were mixed simultaneously with a 1% rabbit
erythrocyte suspension (to label all mature guinea pig T cells
[22]) and either a 1% EA,u or a 1% EAy suspension. The
number of cells forming rosettes with both types of erythro-
cytes was enumerated, based on a marked difference in the
size of ox and rabbit erythrocytes (19). Cells with two or
more attached rabbit erythrocytes and two or more EA,u (or
EA-y) cells were scored as Tp. (or T-y) cells, respectively, and
the data are expressed as a percentage of total T cells in each
suspension.
Statistical analysis. The analysis of variance was used to
test the effects of the independent variable (vaccination) on
the various dependent variables that were measured. The
significance of differences between means was assessed by
the Duncan new multiple range test (23). A 95% confidence
level was set for all tests.
RESULTS
Tuberculin responses and anti-mycobacterial resistance.
BCG-vaccinated guinea pigs exhibited significantly (P <
0.01) stronger delayed-type hypersensitivity reactions to 100
tuberculin units of PPD than their nonvaccinated counter-
parts did during the first three intervals tested (Table 1).
Nonvaccinated animals displayed minimal responses during
the first 2 weeks postchallenge; however, as the disease
progressed, nonvaccinated guinea pigs were capable of
mounting a significant dermal reaction to PPD which was not
significantly different from that of BCG-vaccinated guinea
pigs by week 4.
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TABLE 1. Effect of BCG vaccination on delayed-type
hypersensitivity reactions to 100 tuberculin units of PPD and
recovery of viable mycobacteria from the spleens of guinea pigs
challenged aerogenically with M. tuberculosis H37Rva
PPD reaction Log1o no. of viable
Interval (wk) (mm induration) organisms/spleen
postchallenge
VACC NV VACC NV
1 12.7 ± 1.9* 1.7 ± 1.6 0.0 ± 0.0 0.0 ± 0.0
2 16.8 ± 0.3* 2.4 ± 1.4 1.17 ± 0.72 1.52 ± 0.88
3 16.3 ± 1.7* 11.5 ± 1.9 2.80 ± 0.97* 4.73 ± 0.18
4 18.5 ± 1.0 14.3 ± 2.4 3.75 ± 0.18* 5.79 ± 0.05
a Results are the means + standard errors of the mean for four to six
observations per interval. VACC, Vaccinated guinea pigs; NV, nonvacci-
nated guinea pigs. *, Significant differences due to vaccination (P < 0.05).
The protective effect of BCG vaccination was apparent in
the spleen viable counts (Table 1). Viable M. tuberculosis
was first detected 2 weeks postchallenge. The first significant
(P < 0.05) effect of vaccination was observed at 3 weeks as
a 100-fold reduction in mycobacterial load which was main-
tained at the 4-week interval.
Lymphoproliferation in vitro. Results of lymphocyte pro-
liferation to ConA and tuberculin PPD in vitro are given in
Table 2. PPD-induced blastogenesis was more pronounced
in peripheral blood lymphocytes of BCG-vaccinated animals
than it was in nonvaccinated animals in the first two sacrifice
intervals. By 3 weeks fdllowing respiratory challenge with
M. tuberculosis H437Rv, lymphocytes from nonvaccinated
animals responded vigorously to PPD in vitro.
Lymphoproliferative responses of peripheral blood cells
to ConA were strong and uniform across sacrifice intervals
within each treatment group. During each interval lympho-
cytes from guinea pigs receiving the M. bovis BCG vaccine
were significantly (P < 0.05) more responsive to the nonspe-
cific mitogen than lymphocytes from animals that were not
vaccinated, in spite of considerable variation from animal to
animal.
The spontaneous proliferation of unstimulated (control)
cells was low (400 to 900 cpm) and did not vary significantly
with the treatment group from which the cells were obtained.
Impact ofBCG vaccitiation on T,u cells. Figure 1 illustrates
that vaccination resulted in significantly (P < 0.05) enhanced
proportions of T lymphocytes bearing Fc receptors for IgM
in the peripheral blood during the first 2 weeks following
respiratory challenge with virulent M. tuberculosis. In other
experiments, it was determined that base-line levels of Tp.
cells in the blood of nonchallenged animals were 20 ± 2%. At
3 and 4 weeks postinfection, vaccinated guinea pigs still
demonstrated increased percentages of T[L cells, although
the difference was not statistically significant. Calculations
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FIG. 1. Influence of BCG vaccination on the proportion of T,u
cells present in the peripheral blood of vaccinated (0) and nonvac-
cinated (0) guinea pigs challenged by the respiratory route with
virulent M. tuberculosis H37Rv; values are means + standard errors
of the mean for four to six animals per point.
of absolute numbers based on total leukocyte counts of the
same blood samples also indicated enhancement of T,-cell
populations in the circulation of BCG-vaccinated animals to
an even greater extent than that observed with the percent-
ages (e.g., at week 4, vaccinated animals had 613 123 T,u
cells per mm3 and nonvaccinated animals had 354 54 TRuz
cells per mm3).
Examination of the percentages of splenic T,u cells (Fig. 2)
showed that BCG-vaccinated animals possessed signifi-
cantly increased proportions of splenic T,u cells compared
with the nonvaccinated counterparts at both 2 and 3 weeks
following virulent, pulmonary infection. However, by the
4-week interval the percentage of splenic T,u cells present in
vaccinated and nonvaccinated guinea pigs approached sim-
ilar values. Nonchallenged guinea pigs were found to have
base-line levels of splenic T,u cells equivalent to those
observed in nonvaccinated animals during weeks 1 to 3.
Effect of BCG vaccination on Ty cells. In the peripheral
blood, T cells expressing Fc receptors for IgG (T-y) remained
unaffected by M. bovis BCG vaccination (Fig. 3). In general,
a significant downward trend in T-y-cell proportions was
observed as the pulmonary infection progressed during the
first 3 weeks following aerogenic infection. No major differ-
ences in Ty-cell numbers between vaccinated and nonvac-
cinated guinea pigs were demonstrated when absolute T-y
values were calculated (data not shown).
Similar results were observed for this T-cell subset in the
spleen (Fig. 4). BCG vaccination did not significantly influ-
ence the proportion of Ty cells in the spleen; however, a
significant depression in T-y percentages was detected over
TABLE 2. Influence of BCG vaccination on in vitro lymphoproliferation of peripheral blood lymphocytes from
guinea pigs challenged aerogenically with M. tuberculosis H37Rva
Vaccination Stimulation index at week":Treatment statUSb1 2 3 4
PPD VACC 18.5 ± 0.5* 250.3 ± 103.1* 154.4 ± 87.8 241.7 ± 113.9
NV 1.4 ± 0.8 2.3 ± 1.2 254.3 ± 121.2 101.7 ± 54.9
ConA VACC 738.6 + 18.5* 302.4 ± 159.0 431.8 ± 167.4* 440 + 246.6*
NV 257.1 ± 84.7 176.7 ± 47.6 162.5 ± 48.9 147.4 ± 47.0
a Results are means ± standard errors of the mean for four to six animals per treatment.
b VACC, Vaccinated guinea pigs; NV, nonvaccinated guinea pigs.
*, Significant differences because of vaccination (P < 0.05).
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FIG. 2. Proportions of T,u cells in the spleens or
(@) and nonvaccinated (0) guinea pigs at weekly i]
pulmonary challenge with virulent M. tuberculos
are means + standard errors of the mean for four
point.
the course of the first 3 weeks of tuberculous
nonvaccinated and BCG-vaccinated guinea
upswing in proportion beginning by 4 weeks
sol infection with virulent M. tuberculosis.:
of T-y cells in both organs in nonchallenged g
estimated to be about the same as the propo
at 3 weeks in nonvaccinated guinea pigs.
DISCUSSION
We demonstrated that BCG vaccination
immunoregulatory events in guinea pigs v
tuberculosis by affecting the proportion and
Fc receptor-bearing T-cell subsets. Specifica
nation of tuberculous guinea pigs resulted
elevation in the proportions of T,u cells in
blood within the first 3 weeks following r(
lenge. Levels of Ty cells declined in all tis
first 3 weeks of infection. Vaccination with
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FIG. 3. Percentage of T-y cells in the blood of
(@) and nonvaccinated (0) guinea pigs infected v
virulent M. tuberculosis H37Rv; values are means
of the mean for four to six animals per point.
4
f BCG-vaccinated
ntervals following
is H37Rv; values
to six animals per
disease in both
i pigs, with an
r_ ___
-O
CO
-J
UJ
C)I-
I~-
z
C)
CL
20-
18-
16-
14-
12-
10- I
0 1 2 3 4
WEEKS POST CHALLENGE
FIG. 4. Effect of vaccination on levels of T-y cells in the spleens
of BCG-vaccinated (0) and nonvaccinated (0) guinea pigs at weekly
intervals following respiratory infection with virulent M. tuberculo-
sis H37Rv; values are means + standard errors of the mean for four
to six animals per point.
,ollowing aero- ated significant delayed-type hypersensitivity reactions to
Base-line levels tuberculin (PPD), as well as increased proliferative re-
,uinea pigs were sponses of peripheral blood lymphocytes to PPD in vitro.
irtions observed Previously, it has been demonstrated that BCG vaccination
is efficacious against respiratory challenge with virulent M.
tuberculosis H37Rv in the guinea pig model (2, 12, 13, 21).
Successful vaccination minimizes hematogenous dissemina-
tion of tubercle bacilli to distal organs such as the spleen,
may modulate resulting in significant reductions in the mycobacterial load
Ivith pulmonary in that organ (Table 1). BCG also allows the animal to
1 dlstrbution of control the accumulation of mycobacteria in the primarylnly, BCG vacci- lung lesion during the first few weeks following low-doseIn a slgnificant pulmonary challenge (21). However, since the principalthe spleen and effect of vaccination appears to be the control of the dissem-
-spiratory chal- ination phase of infection (20), spleen viable counts are a
'sues durng the better indication of the degree of resistance that is conferred.
BCG also elici- Cellular responses of vaccinated guinea pigs to tuberculin,
both in vivo and in vitro, were predictable. Vaccinated
animals responded vigorously to PPD skin tests at each
interval that they were observed. As tuberculous disease
progressed in nonvaccinated guinea pigs, the presence of a
greater antigenic stimulus allowed for the development of a
cell-mediated immune response, and these animals eventu-
ally mounted a cutaneous reaction to the intradermal deliv-
ery of mycobacterial antigen. In vitro tuberculin responses
mimicked those demonstrated in vivo. Vaccinated guinea
pigs exhibited more dramatic stimulation indices earlier in
the disease process than nonvaccinated animals did, indicat-
ing an accelerated amplification of PPD-reactive T-cell
clones in vaccine recipients. The development of tuberculin-
reactive lymphocytes in the peripheral blood of nonvacci-
nated guinea pigs required a longer interval following respi-
ratory infection. However, the acquisition of PPD-
responsive cells in the circulation of nonvaccinated animals
3 4 correlated with conversion to tuberculin reactivity in the
skin. It is important that neither of these events was associ-
LENGE ated with any evidence of anti-mycobacterial resistance in
f BCG-vaccinated nonvaccinated guinea pigs, at least as assessed by spleen
vith an aerosol of viable counts (Table 1).
± standard errors Blastogenic responses of peripheral blood lymphocytes to
the nonspecific T-cell mitogen ConA indicate a generalized,
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1378 BARTOW AND McMURRAY
as well as antigen-specific, enhancement of lymphoprolifer-
ation by BCG vaccination. This nonspecific augmentation in
T-cell function following BCG vaccination has been ob-
served previously (10).
Prior BCG vaccination in guinea pigs with pulmonary
tuberculosis significantly increased the proportion of T,u
cells in both peripheral blood and spleens. The maximum
percentage of T,u cells attained in the spleens of vaccinated
animals correlated with the first detection of viable M.
tuberculosis recovered from that organ 2 weeks postchal-
lenge (Table 1). Thus, the appearance of elevated levels of
TR cells in the spleens precedes the demonstration of
significant control of mycobacteria in that organ by 1 week
(Table 1). We interpret this delay to reflect the time neces-
sary for these putative regulatory TR cells to exert their
beneficial effect on the anti-mycobacterial mechanisms, re-
sulting in a reduced rate of mycobacteria accumulation
which becomes detectable 7 days later. A temporal relation-
ship was also observed between TR-cell levels in the periph-
eral blood of vaccinated guinea pigs and PPD reactivity. The
early increase in T,u-cell percentages circulating in vacci-
nated animals during the first 2 weeks of infection corre-
sponded to the initial presence of significant tuberculin
responses both in vivo and in vitro. The later acquisition of
PPD reactivity in nonvaccinated guinea pigs occurred con-
comitantly with increases in Tp-cell values at 4 weeks in
both blood and spleens, similar to those observed in vacci-
nated animals. The fact that increased Tp-cell levels oc-
curred at a time (4 weeks) when the spleen viable counts
were high (Table 1) may reflect the inadequacy of this
late-developing protective response to deal effectively with
very high bacillary loads, rather than implying no beneficial
role for the T,u-cell population. These associations are
admittedly correlative, and the formal demonstration of a
regulatory role for T,u cells must await studies with purified
or depleted cell populations.
Although this is the first published report of T,u cells in
animals with tuberculosis, others have examined so-called
T-non-y cells, a population presumably containing Tp cells as
well as other T cells (7). The precise antigen recognition
capability of T,u cells remains to be determined. This initial
significant elevation of the putative helper (T,u)-cell subset in
BCG-vaccinated guinea pigs may contribute to the enhance-
ment of the anti-tuberculous response and help prevent
disease progression in these animals.
No effect of BCG vaccination on T-y-cell proportions was
detected in either the spleens or peripheral blood of guinea
pigs infected with M. tuberculosis. However, both vacci-
nated and nonvaccinated guinea pigs had elevated T-y-cell
levels in the spleens and peripheral blood during the first
week following aerogenic challenge. Disease duration was
associated with a progressive decline in T-y-cell subsets in
both organs. However, the rebound initiated at 4 weeks
suggests an elevation in T-y percentages in the later stages of
disease. These results would be in concordance with those of
Kleinhenz and Ellner (8), who demonstrated increased Ty-
cell percentage in patients presenting with clinical tubercu-
losis and who were presumably much further into the disease
process. Our study concentrated primarily on events that
occur early in infection. The initial decline in T-y-cell per-
centages that we observed may be attributed to a temporary
shedding of the Fc-y receptor or a departure of Ty cells to
peripheral tissue sites.
Factors which may modify the proportions of T,u and T-y
cells in tuberculous animals include their antigenic reactivity
and their interaction with antigen-antibody complexes con-
taining the homologous isotype. Tsuyuguchi et al. (24) have
demonstrated increased levels of Ty cells in the peripheral
blood lymphocytes of patients with tuberculosis following
culture with PPD in vitro. On the other hand, culture of Ty
cells with immune complexes containing IgG is known to
cause shedding or internalization of Fc receptors, which are
reexpressed only after some time in culture (15).
Two types of suppressor cells in patients with active
pulmonary tuberculosis have been demonstrated: an adher-
ent mononuclear cell population and T lymphocytes bearing
Fc receptors for IgG (3, 7). It has been suggested that T-y
cells may play a dichotomous role in the regulation of the
anti-tuberculous response (7). Coculture studies conducted
in patients with active tuberculosis demonstrated that puri-
fied Ty cells depressed PPD-induced blastogenesis ofT-nony
cells; however, they also demonstrated that T-y cells served
to down-regulate monocyte-induced suppression (8). In an-
other study, Ty cells were cited as the target population for
a soluble suppressor factor (26). The functional heterogene-
ity of Ty cells may allow for the coordination of immuno-
regulatory events involved in maintaining the balance be-
tween antigen reactivity and suppression.
Using a highly relevant guinea pig model of pulmonary
tuberculosis, we applied a functional assay for the presence
of Fc receptors on T lymphocytes to study BCG vaccine-
induced resistance to respiratory tuberculosis infection.
There is sufficient clinical and experimental evidence to
suggest a role for FcR+ cells in the regulation of immunity in
patients with tuberculosis (8, 24). BCG vaccination stimu-
lated antigen-specific T-cell responses both in vivo and in
vitro and has been shown to obviate disease progression.
T-cell subsets defined by the presence of Fc receptors,
particularly Tp. cells, could mediate this BCG-induced dis-
ease resistance. It may be that the Fc-receptor-bearing T cell
serves as an intermediary between the humoral and cell-
mediated arms of the immune response, coordinating the
balance between the heterogeneous cell populations in-
volved in generating functional immunity. Future work to
define the role of FcR+ T cells in the anti-tuberculous
response will involve the study of purified TRx- and T-y-cell
populations both in vivo and in vitro. Identification of the
specific cell populations pertinent to the acquisition of suc-
cessful anti-tuberculous immunity will aid in the develop-
ment of new and more efficacious means for controlling, if
not eradicating, tuberculosis throughout the world.
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